Skip to main content

Advertisement

Log in

Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

The prognostic factors which can improve the overall survival (OS) of patients with T4 gastric carcinoma (GC) are still controversial: a meta-analysis was conducted to analyze the impact of clinicopathological parameters on survival after MOR among patients with T4 GC.

Methods

A systematic search was performed. Odd risks (ORs) of patients with T4 GC were used to calculate the relationship between clinicopathological parameters and OS.

Results

Nine studies involving 941 patients with T4 GC were identified. Well-moderate differentiation led to increased 1-, 3-, 5-year OS with an OR of 2.63, 1.58 and 1.45. Borrmann type I–II led to increased 1-, 3-year OS with an OR of 1.67 and 2.08. No lymph node metastasis led to increased 1-, 3-, 5-year OS with an OR of 7.16, 3.18 and 3.71. Total gastrectomy led to increased 1-, 3-year OS with an OR of 2.01 and 1.79. ≥2 Organs resected led to increased 1-, 3-year OS with an OR of 2.19 and 2.19. TNM stage II–III led to increased 1-, 3-year OS with an OR of 3.68 and 5.75. Curative resection led to increased 1-, 3-, 5-year OS with an OR of 4.46, 5.80 and 5.98.

Conclusion

Well-moderate differentiation, Borrmann type I–II, no lymph node metastasis, total gastrectomy, ≥2 organs resected, TNM stage II–III and curative resection were positive prognostic factors for OS of patients with T4 GC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, et al. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014;50(7):1330–44.

    Article  PubMed  Google Scholar 

  2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–50.

    Article  PubMed  Google Scholar 

  3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

    Article  CAS  PubMed  Google Scholar 

  4. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol/Hematol. 2005;54(3):209–41.

    Article  Google Scholar 

  5. Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, et al. Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma. Ann Surg. 2015;262(6):991–8.

    Article  PubMed  Google Scholar 

  6. Jeong O, Choi WY, Park YK. Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs. J Surg Oncol. 2009;100(2):115–20.

    Article  PubMed  Google Scholar 

  7. Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Surgical outcomes in patients with T4 gastric carcinoma. J Am Coll Surg. 2006;202(2):223–30.

    Article  PubMed  Google Scholar 

  8. Kim DY, Joo JK, Seo KW, Park YK, Ryu SY, Kim HR, et al. T4 gastric carcinoma: the benefit of non-curative resection. ANZ J Surg. 2006;76(6):453–7.

    Article  PubMed  Google Scholar 

  9. Saito H, Kuroda H, Matsunaga T, Fukuda K, Tatebe S, Tsujitani S, et al. Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol. 2010;101(7):622–5.

    Article  PubMed  Google Scholar 

  10. Zu G, Ji A, Zhou T, Che N. Clinicopathological significance of SIRT1 expression in colorectal cancer: a systematic review and meta-analysis. Int J Surg. 2016;26(2):32–7.

    Article  PubMed  Google Scholar 

  11. Carboni F, Lepiane P, Santoro R, Lorusso R, Mancini P, Sperduti I, et al. Extended multiorgan resection for T4 gastric carcinoma: 25-year experience. J Surg Oncol. 2005;90(2):95–100.

    Article  PubMed  Google Scholar 

  12. Oñate-Ocaña LF, Becker M, Carrillo JF, Aiello-Crocifoglio V, Gallardo-Rincón D, Brom-Valladares R, et al. Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma. J Surg Oncol. 2008;98(5):336–42.

    Article  PubMed  Google Scholar 

  13. Ozer I, Bostanci EB, Orug T, Ozogul YB, Ulas M, Ercan M, et al. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer. Am J Surg. 2009;198(1):25–30.

    Article  PubMed  Google Scholar 

  14. Cheng CT, Tsai CY, Hsu JT, Vinayak R, Liu KH, Yeh CN, et al. Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth? Ann Surg Oncol. 2011;18(6):1606–14.

    Article  PubMed  Google Scholar 

  15. Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T, et al. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer. Am J Surg. 2012;203(1):107–11.

    Article  PubMed  Google Scholar 

  16. Xiao L, Li M, Xu F, Ye H, Wu W, Long S, et al. Extended multi-organ resection for cT4 gastric carcinoma: a retrospective analysis. Pak J Med Sci. 2013;29(2):581–5.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Shan G, Rong Y, Jiang D, Zhu D, Zhang L, Jiang J. Prognostic analysis for patients with T4 gastric cancer undergoing radical resection. Chin J Gen Surg. 2013;22(10):1271–5.

    Google Scholar 

  18. Yiming L, Latengbaolide A, Bo C, Caigang L, Huimian X. Comparison of surgical methods and prognostic factors in T4 gastric cancer. Chin Ger J Clin Oncol. 2010;9(7):391–5.

    Article  Google Scholar 

  19. Lin D, Ping L, Liu C, Wang H, Altbad W, Zhao C, et al. Surgical outcomes in patients with T4 gastric carcinoma: a retrospective study of 162 patients. Chin Ger J Clin Oncol. 2009;8(10):599–602.

    Article  Google Scholar 

  20. McCulloch P. The role of surgery in patients with advanced gastric cancer. Best Pract Res Clin Gastroenterol. 2006;20(4):767–87.

    Article  PubMed  Google Scholar 

  21. McCullough JA, Evoy D, Sweeney KJ, Meyers C, Ravi N, Keeling N, et al. D2 lymphadenectomy in the management of gastric cancer. Ir J Med Sci. 2003;172(3):132–5.

    Article  CAS  PubMed  Google Scholar 

  22. Radovanović D, Stevanović D, Pavlović I, Bajec A, Vekić B, Mitrović N. Multiorgan resection in patients with gastric cancer. Med Pregl. 2004;57(9–10):480–6.

    Article  PubMed  Google Scholar 

  23. Kim ER, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ, et al. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2015;102(11):1394–401.

    Article  CAS  PubMed  Google Scholar 

  24. Isozaki H, Tanaka N, Tanigawa N, Okajima K. Prognostic factors in patients with advanced gastric cancer with macroscopic invasion to adjacent organs treated with radical surgery. Gastric Cancer. 2000;3(4):202–10.

    Article  PubMed  Google Scholar 

  25. Kobayashi A, Nakagohri T, Konishi M, Inoue K, Takahashi S, Itou M, et al. Aggressive surgical treatment for T4 gastric cancer. J Gastrointestinal Surg. 2004;8(4):464–70.

    Article  Google Scholar 

  26. Kim JH, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, et al. Surgical outcomes and prognostic factors for T4 gastric cancers. Asian J Surg. 2009;32(4):198–204.

    Article  PubMed  Google Scholar 

  27. Climent M, Hidalgo N, Vidal Ó, Puig S, Iglesias M, Cuatrecasas M, et al. Postoperative complications do not impact on recurrence and survival after curative resection of gastric cancer. Eur J Surg Oncol. 2016;42(1):132–9.

    Article  CAS  PubMed  Google Scholar 

  28. Jiang N, Deng JY, Ding XW, Zhang L, Liu HG, Liang YX, et al. Effect of complication grade on survival following curative gastrectomy for carcinoma. World J Gastroenterol. 2014;20(25):8244–52.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

G. Zu and X. Zhang designed the research; W. Li and T. Zhang conducted the research; W. Li and Y. Sun analyzed data; G. Zu wrote the draft; all authors read, reviewed and approved the final manuscript. G. Zu and X. Zhang had primary responsibility for final content.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to G. Zu or X. Zhang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zu, G., Zhang, T., Li, W. et al. Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis. Clin Transl Oncol 19, 750–760 (2017). https://doi.org/10.1007/s12094-016-1600-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-016-1600-3

Keywords

Navigation